← SynDRA
LEVOBUPIVACAINE
SynDRA canonical compound SYN0023458 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · OTC |
| Primary target(s) | KCNA5 |
| Mechanism of action | voltage-gated potassium channel blocker |
| Indication | local anesthetic |
| Disease area | Anesthesia |
All known targets
- KCNA5
- SCN4A
- CYP2D6
- HTR3A
- KCND3
- KCNH2
- PTGER1
- SCN1A
Mechanisms of action (all sources)
- SCN4A BLOCKER
- Sodium channel protein type IV alpha subunit blocker
- voltage-gated potassium channel blocker
Drug classes
- Anesthetics
- Anesthetics, Local
- Central Nervous System Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
ATC classes
- N01B · ANESTHETICS, LOCAL
Cross-references
Synonyms
- chirocain
- levobupivacaine hydrochloride
- levobupivacaine HCl
- Levobupivacaina
- Bupivacaine (-)-form
- (-)-bupivacaine
- (s)-bupivacaine
- Bupivacaine, (-)-
- Bupivacaine, (s)-
- L-bupivacaine
- Novabupi
- Chirocaine (TN)
- Levobupivacaine (INN)
- Levobupivacaine [INN:BAN]
- Novabupi (TN)
- L(-)-Bupivacaine
- L-(-)-bupivacaine
- L-(-)-1-Butyl-2',6'-pipecoloxylidide
- (2S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
- (S)-1-Butyl-2',6'-pipecoloxylidide
- (S)-bupivacaine
- A5H73K9U3W
- CHEBI:6149
- 2',6'-Pipecoloxylidide, 1-butyl-, L-(-)-
- (s)-1-butyl-n-(2,6-dimethylphenyl)-2-piperidinecarboxamide
- levobupivacainum
- Bupivacaine (-)-
- RefChem:153196
- DTXCID8028470
- N01BB10
- (S)-(-)-Bupivacaine
- (S)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
- (2S)-1-butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
- MFCD00936851
- LEVOBUPIVACAINE [INN]
- Levobupivacaine free base
- NCGC00159482-02
- UNII-A5H73K9U3W
Reported adverse events
- Cardiac arrest
- ANA
- Bradycardia
- Restlessness
- Chondrolysis
- Hypertension
- Infusion
- Arachnoiditis
- Headache
- Hypoaesthesia
- Pyrexia
- Acne
Look up LEVOBUPIVACAINE in the interactive SynDRA portal →